Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T15766 |
Lirimilast
BAY 19-8004 |
PDE | Metabolism |
Lirimilast is an effective, selective, and orally active phosphodiesterase-4 (PDE4) inhibitor (IC50: 49 nM). Lirimilast has potently anti-inflammatory properties. Lirimilast can be used for the treatment of asthma or chronic obstructive pulmonary disease. |